BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4214866)

  • 1. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin.
    Gallin JI; Kaplan AP
    J Immunol; 1974 Dec; 113(6):1928-34. PubMed ID: 4214866
    [No Abstract]   [Full Text] [Related]  

  • 2. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
    Kaplan AP; Kay AB; Austen KF
    J Exp Med; 1972 Jan; 135(1):81-97. PubMed ID: 5009705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
    Dubin A; Potempa J; Travis J
    Prep Biochem; 1990; 20(1):63-74. PubMed ID: 1694995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hageman factor dependent pathways of human plasma.
    Kaplan AP
    Microvasc Res; 1974 Jul; 8(1):97-111. PubMed ID: 4278345
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
    Harpel PC; Lewin MF; Kaplan AP
    J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.
    Chan JY; Burrowes CE; Habal FM; Movat HZ
    Biochem Biophys Res Commun; 1977 Jan; 74(1):150-8. PubMed ID: 65173
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP; Goetzl EJ; Austen KF
    J Clin Invest; 1973 Oct; 52(10):2591-5. PubMed ID: 4729052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-induced kinin (bradykinin) formation: activation of Hageman factor and plasma kallikrein in human plasma.
    Pettinger WA; Young R
    Life Sci; 1970 Mar; 9(6):313-22. PubMed ID: 4986289
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
    Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
    [No Abstract]   [Full Text] [Related]  

  • 16. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor.
    Ravindran S; Grys TE; Welch RA; Schapira M; Patston PA
    Thromb Haemost; 2004 Dec; 92(6):1277-83. PubMed ID: 15583734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of bradykinin generation in human plasma.
    Kaplan AP
    Monogr Allergy; 1983; 18():272-6. PubMed ID: 6358866
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
    Bury AF; Barrett AJ
    Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
    Harpel PC; Rosenberg RD
    Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.